Abstract
In this study, we identified lysine residues in the fibrinogen A alpha chain that serve as substrates during transglutaminase (TG)-mediated cross-linking of plasminogen activator inhibitor 2 (PAI-2), Comparisons were made with alpha(2)-antiplasmin (alpha(2)-AP), which is known to cross-link to lysine 303 of the A alpha chain. A 30-residue peptide containing Lys-303 specifically competed with fibrinogen for cross-linking to alpha(2)-AP but not for crosslinking to PAI-2, Further evidence that PAI-2 did not cross-link via Lys-303 was the cross-linking of PAI-2 to I-9 and des-alpha C fibrinogens, which lack 100 and 390 amino acids from the C terminus of the A alpha chain, respectively. PAI-(2) or alpha(2)-AP was cross-linked to fibrinogen and digested with trypsin or endopeptidase Glu-C, and the resulting peptides analyzed by mass spectrometry, Peptides detected were consistent with tissue TG (tTG)-mediated cross-linking of PAI-2 to lysines 148, 176, 183, 457 and factor XIIIa-mediated cross-linking of PAI-2 to lysines 148, 230, and 413 in the A alpha chain. alpha(2)-AP was crosslinked only to lysine 303, Cross-linking of PAI-S to fibrinogen did not compete with alpha(2)-AP, and the two proteins utilized different lysines in the A alpha chain. Therefore, PAI-2 and alpha(2)-AP can cross-link simultaneously to the alpha polymers of a fibrin clot and promote resistance to lysis.
Original language | English |
---|---|
Pages (from-to) | 24915-24920 |
Number of pages | 6 |
Journal | The Journal of Biological Chemistry |
Volume | 275 |
Publication status | Published - 2000 |
Keywords
- AMINO-ACID SEQUENCE
- HUMAN-FIBRINOGEN
- ALPHA-2-PLASMIN INHIBITOR
- ALPHA-CHAIN
- STABILIZING FACTOR
- PLASMA-FIBRINOGEN
- CRYSTAL-STRUCTURE
- FACTOR-XIIIA
- TRANSGLUTAMINASES
- TYPE-2